STOP-DM
Biomarker1 paper1 finding
- Humans1
Associations
16-month pancreatic cancer risk
upin humans1
1 study
6-month pancreatic cancer risk
upin humans1
STOP-DM predicts 6-month pancreatic cancer risk in humans (External validation AUC 0.86 (95% CI 0.83–0.89)).
HumansExternal validation in the Xiamen Regional Electronic Health Record Database among individuals with type 2 diabetes6 monthsn = 105,537
Model estimates pancreatic cancer risk in type 2 diabetes · Gut · 6 Oct 2026
Latest
1GutHumans
Model estimates pancreatic cancer risk in type 2 diabetes
At six months, the model’s ability to distinguish cancer cases from non-cases scored 0.88 in development, 0.89 in internal validation and 0.86 in…At six months, the model’s ability to distinguish cancer cases from non-cases scored 0.88 in development, 0.89 in internal validation and 0.86 in external validation.